Medical device manufacturer OrbusNeich Medical Inc., and its unit, OrbusNeich Medical GmbH together announced that they gained a preliminary injunction from the Dusseldorf Regional Court in the stent patent infringement proceedings against Boston Scientific Corporation (BSX) and its German distribution unit.
OrbusNeich had filed suit in the German Court in February, charging Boston Scientific with infringing two patents covering certain novel stent designs developed by OrbusNeich.
Now, the court found that the stent design of Boston Scientific's Small Vessel, Small Workhorse and Workhorse stents of the affected product lines, those used in vessels of 4.0 mm or less in diameter, infringe the German part of the '482 Patent.
OrbusNeich can now prevent Boston Scientific from selling the affected stent lines in Germany. The court decision also allows the seizure of stents Boston Scientific Medizintechnik GmbH sold in Germany, but not used.
For comments and feedback: editorial@rttnews.com